Concepedia

Yeongmin Kim

YK

Statistics

Publications

7

Citations

454

H-Index

7

Active since

2021

Affiliations

Gwangju Institute of Science and Technology(Current)

Genome and Company (South Korea)

Jackson Laboratory

Samsung Medical Center

Chosun University Hospital

Yeongmin Kim is an author at Gwangju Institute of Science and Technology specializing in immunology, cancer immunotherapy, and life sciences.

ORCID

Publications per year

2021–2025

7

Publications

7

Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice

Se‐Hoon Lee, Sung‐Yup Cho, Youngmin Yoon et al. · Nature Microbiology · 2021 · 317 citations

, , +16

Bifidobacterial carbohydrate/nucleoside metabolism enhances oxidative phosphorylation in white adipose tissue to protect against diet-induced obesity

Gihyeon Kim, Youngmin Yoon, Jin‐Ho Park et al. · Microbiome · 2022 · 59 citations · Full text

, , +17

Intracellular Adhesion Molecule‐1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8<sup>+</sup> T Cells

Se‐Hoon Lee, Yeongmin Kim, Bu‐Nam Jeon et al. · Advanced Science · 2023 · 23 citations · Full text

, , +17

Practical prediction model of the clinical response to programmed death-ligand 1 inhibitors in advanced gastric cancer

Myung‐Giun Noh, Youngmin Yoon, Gihyeon Kim et al. · Experimental & Molecular Medicine · 2021 · 22 citations · Full text

, , +17

Association of Appendicular Skeletal Muscle Mass Index and Insulin Resistance With Mortality in Multi‐Nationwide Cohorts

Shinje Moon, Jong Wook Choi, Jung Hwan Park et al. · Journal of Cachexia Sarcopenia and Muscle · 2025 · 12 citations · Full text

, , +17

1–5 of 7